Novel therapies and vaccines based on mRNA substances as well as cell and gene therapies are becoming increasingly important , but these active pharmaceutical ingredients (APIs) are particularly sensitive. They are stored and transported on dry ice at temperatures of down to -100 °C. In addition, many APIs must be protected against light. For these applications, Schreiner MediPharm has developed the novel Freeze-Light-Protect syringe label.

Ever since the coronavirus pandemic mRNA substances not only have been on everyone’s lips but the exacting requirements to be met in transportation and storage have also become common knowledge. The Freeze-Light-Protect label from Schreiner MediPharm addresses exactly these challenges. The marking label reliably adheres to the syringe even at low sub-zero temperatures. In addition, the label can be equipped with a variety of UV and light protection levels: from pure UV protection to protection against UV rays and blue light to complete light protection—depending on the customer’s requirement.

The innovative label from Schreiner MediPharm was developed in coordination with its partner SCHOTT Pharma that introduced the matching syringe on the market: SCHOTT TOPPAC® freeze. The 1 m long COC syringe is designed for drugs at temperatures as low as -100 °C with a focus on retaining reliable syringe functionality as well as syringe closure integrity and thus ensure drug stability. Freeze-Light-Protect was tested specifically for the SCHOTT TOPPAC® freeze syringe to document the reliability of the label-integrated protective functions and to underscore product and patient safety.

Moreover, additional functionalities can be integrated in the label from Schreiner MediPharm: detachable documentation labels for vaccination certificates or patients’ medical records, inspection windows for checking the syringe content in true color, and a graduation for correct dosing when performing the injection. With the combination of Freeze-Light-Protect and SCHOTT TOPPAC® freeze, pharmaceutical companies are provided with a prequalified solution that can be customized according to their specific application—thanks to the concentrated expertise of Schreiner MediPharm and SCHOTT Pharma.